A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study will assess the relationship between fulvestrant dose and efficacy, and determine
the dosing regimen as a second line therapy for Japanese postmenopausal women with oestrogen
receptor positive advanced breast cancer.